Charles River Laboratories
617 hedge funds and large institutions have $10.3B invested in Charles River Laboratories in 2023 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 241 increasing their positions, 214 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
617
Holders Change
-7
Holders Change %
-1.12%
% of All Funds
9.88%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
76
Increased
241
Reduced
214
Closed
68
Calls
$48.9M
Puts
$38.1M
Net Calls
+$10.8M
Net Calls Change
+$33.8M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$132M |
| 2 |
SCA
Southpoint Capital Advisors
New York
|
+$80.7M |
| 3 |
FAM
Fred Alger Management
New York
|
+$47.9M |
| 4 |
CI Investments Inc
Toronto,
Ontario, Canada
|
+$44.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.7M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$66.2M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$59.8M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$45.9M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$45.4M |
| 5 |
BlackRock
New York
|
-$34.6M |
